ZAI LAB(09688),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

ZAI LAB(09688)

15.500-0.620-3.85%

CommunityCommunity
NewsNews
ProfileProfile
AnnouncementsAnnouncements

- BUZZ-Shares of Chinese brokerage Guolian Securities jump on acquisition plan
  Reuters · 05-15
  BUZZ-Shares of Chinese brokerage Guolian Securities jump on acquisition plan
- BRIEF-Zai Lab Announces Acceptance of Supplemental Biologics License Application with Priority Review for Efgartigimod Alfa Injection (Subcutaneous Injection) in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in China
  Reuters · 05-14
  BRIEF-Zai Lab Announces Acceptance of Supplemental Biologics License Application with Priority Review for Efgartigimod Alfa Injection (Subcutaneous Injection) in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in China
- BUZZ-China's Zai Lab hits 3-month peak as NMPA approves lung cancer drug
  Reuters · 05-13
  BUZZ-China's Zai Lab hits 3-month peak as NMPA approves lung cancer drug
- BRIEF-Zai Lab Says China's NMPA Approved AUGTYROTM (REPOTRECTINIB)
  Reuters · 05-13
  BRIEF-Zai Lab Says China's NMPA Approved AUGTYROTM (REPOTRECTINIB)
- BUZZ-China's Zai Lab Hong Kong stock jumps most in 16 months on revenue jump
  Reuters · 05-09
  BUZZ-China's Zai Lab Hong Kong stock jumps most in 16 months on revenue jump
- BRIEF-JPMorgan Chase & Co's Long Position In Zai Lab Increases To 13.64% On April 23 - HKEX
  Reuters · 04-26
  BRIEF-JPMorgan Chase & Co's Long Position In Zai Lab Increases To 13.64% On April 23 - HKEX
- BRIEF-Zai Lab Says FY Net Loss $334.6 Million
  Reuters · 03-28
  BRIEF-Zai Lab Says FY Net Loss $334.6 Million
- BRIEF-Zai Lab Entered Into Uncommitted Facility Letter With The Bank Of China (Hong Kong) Limited
  Reuters · 02-09
  BRIEF-Zai Lab Entered Into Uncommitted Facility Letter With The Bank Of China (Hong Kong) Limited
- BRIEF-UBS Group AG's Long Position In Zai Lab Ltd Reduced To 4.95% On Feb 2 - HKEX
  Reuters · 02-08
  BRIEF-UBS Group AG's Long Position In Zai Lab Ltd Reduced To 4.95% On Feb 2 - HKEX
- BUZZ-China's Zai Lab rises on product inclusion in National Reimbursement Drug List
  Reuters · 2023-12-13
  BUZZ-China's Zai Lab rises on product inclusion in National Reimbursement Drug List
Company Profile
Company Name
ZAI LAB
Market
SEHK
Establishment Date
- -
Employees
- -
Office Location
- -
Website
http://www.zailaboratory.com
Zip Code
- -
Phone
- -
Fax
- -
Introduction
Zai Lab Ltd is a holding company mainly engaged in the biopharmaceutical field. The Company is focused on discovering or licensing, developing and commercializing proprietary therapeutics that address areas of large unmet medical need in the China market, including oncology, autoimmune and infectious diseases fields. The Company has a broad pipeline of proprietary drug candidates that range from discovery stage to late-stage clinical programs. These include Niraparib (ZL-2306), ZL-2103, ZL-1101 and others.

1D
5D
Day
Week
Month

High

15.900

Open

15.740

Volume%

0.50

Low

15.360

16.120

T/O Rate

0.59%

Most Discussed

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

ZAI LAB(09688)

Company Profile

Most Discussed